Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7795081 in Type 2 Diabetes Mellitus
NCT07112872Phase 2Active, not recruiting
- Sponsor
- Roche
- Start
- Aug 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of RO7795081 in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Aug 2025; status: active, not recruiting.
02
Drugs
RO7795081
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07112872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112872.